OCTP Oxford Cannabinoid Technologies Holdings Plc

TIDMOCTP

RNS Number : 3482U

Oxford Cannabinoid Tech.Holdings

02 December 2021

2 December 2021

Oxford Cannabinoid Technologies Holdings plc

Director Dealings

Oxford Cannabinoid Technologies Holdings plc ("the Company"), announces that it was informed on 1 December 2021 that on 1 December 2021 Clarissa Sowemimo-Coker, the Chief Operating Officer, and Karen Lowe, the Finance Director, had each purchased ordinary shares of GBP0.01 in the Company ("Ordinary Shares").

 
 Director                   Total number of    Price per         Number of Ordinary 
                             Ordinary Shares    Ordinary Share    Shares held 
                             purchased                            following the 
                                                                  purchase 
 Clarissa Sowemimo-Coker    189,594            2.6199 pence      189,594 
                           -----------------  ----------------  ------------------- 
 Karen Lowe                 340,010            2.69 pence        340,010 
                           -----------------  ----------------  ------------------- 
 

PDMR forms are set out below.

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014 (which forms part of domestic UK law pursuant to the European Union (Withdrawal) Act 2018).

The Directors of the Company accept responsibility for the content of this announcement.

Enquiries:

 
 Oxford Cannabinoid Technologies    +44 (0)20 3034 2820 
  Holdings plc                       john@oxcantech.com 
  Dr John Lucas (CEO)                clarissa@oxcantech.com 
  Clarissa Sowemimo-Coker (COO) 
 Cairn Financial Advisers 
  Emily Staples                      +44 (0)20 7213 0897 
  Jo Turner                           +44 (0) 20 7213 0885 
 Walbrook PR Limited                +44 (0)20 7933 8780 
  Paul Vann                          +44 (0)7768 807631 
  Nicholas Johnson                   oxcantech@walbrookpr.com 
 Harbor Access LLC                   Richard.Leighton@HarborAccessllc.com 
  Richard Leighton                    +1 (475) 455 9403 
  Jonathan Paterson 
 
 

About Oxford Cannabinoid Technologies Holdings Plc :

Oxford Cannabinoid Technologies Holdings plc ("OCTP") is the holding company of Oxford Cannabinoid Technologies Ltd ("OCT"), a pharmaceutical company developing prescription cannabinoid medicines for approval by key medicines regulatory agencies worldwide and targeting the U$ multi-billion pain market (together the "Group"). Cannabinoids are compounds found in the cannabis plant that have been shown to have a range of therapeutic effects on the body, including pain relief. The Group has a clearly defined path to commercialisation, revenues and growth.

The Group is developing drug candidates through clinical trials to gain regulatory approval (FDA/MHRA/EMA) that will enable medical professionals to prescribe them with confidence.

The Group's portfolio aims to balance risk, value and time to market, whilst ensuring market exclusivity around all its key activities. The Group's lead compound, OCT461201, is a highly potent and selective CB2 agonist and is being developed by OCT in a solid oral dosage form. OCT is conducting pre-clinical testing and development with pre-clinical trials scheduled for 2022. The Group's product pipeline also uses a balanced drug product strategy that employs phytocannabinoids, cannabinoid derivatives and other novel compounds for the treatment of pain.

OCTP operates a partnership model with external academic and commercial partners, including the University of Oxford.

 
 Notification of a Transaction pursuant to Article 19(1) of Regulation 
  (EU) No. 596/2014 
 1     Details of the person discharging managerial responsibilities/person 
        closely associated 
----  ------------------------------------------------------------------------------------ 
 a.    Name                        Clarissa Sowemimo-Coker 
                                  -------------------------------------------------------- 
 2     Reason for notification 
      --------------------------  -------------------------------------------------------- 
 a.    Position/Status             Chief Operating Officer & General Counsel 
      --------------------------  -------------------------------------------------------- 
 b.    Initial notification/       Initial notification 
        Amendment 
      --------------------------  -------------------------------------------------------- 
 3     Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
      ------------------------------------------------------------------------------------ 
 a.    Name                        Oxford Cannabinoid Technologies Holdings 
                                    plc 
      -------------------------- 
 b.    LEI 
                                                   2138005SRWT4998BCE35 
      --------------------------  -------------------------------------------------------- 
 4     Details of the transaction(s): section to be repeated for 
        (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transactions have 
        been conducted 
      ------------------------------------------------------------------------------------ 
 a.    Description of               Ordinary shares of GBP0.01 each 
        the financial                GB00BMVMRB86 
        instrument, type 
        of instrument 
 
        Identification 
        Code 
      --------------------------  -------------------------------------------------------- 
 b.    Nature of the               Acquisition of ordinary shares of GBP0.01 
        transaction                 each 
      --------------------------  -------------------------------------------------------- 
 
 c.    Price(s) and volume(s)           Price(s)        Volume(s) 
      --------------------------       -------------- 
    2.6199 pence                                        189,594 
   --------------------------------------------------  ----------- 
 
 d.    Aggregated information      N/A - Single Transaction 
 
        - Aggregated Volume 
 
        - Price 
      --------------------------  -------------------------------------------------------- 
 e.    Date of the transaction     1(st) December 2021 
      --------------------------  -------------------------------------------------------- 
 f.    Place of the transaction    London, UK 
      --------------------------  -------------------------------------------------------- 
 
 
 
 Notification of a Transaction pursuant to Article 19(1) of Regulation 
  (EU) No. 596/2014 
 1     Details of the person discharging managerial responsibilities/person 
        closely associated 
----  ------------------------------------------------------------------------------------ 
 a.    Name                         Karen Lowe 
                                   ------------------------------------------------------- 
 2     Reason for notification 
      ---------------------------  ------------------------------------------------------- 
 a.    Position/Status              Finance Director 
      ---------------------------  ------------------------------------------------------- 
 b.    Initial notification/        Initial notification 
        Amendment 
      ---------------------------  ------------------------------------------------------- 
 3     Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
      ------------------------------------------------------------------------------------ 
 a.    Name                         Oxford Cannabinoid Technologies Holdings 
                                     plc 
      --------------------------- 
 b.    LEI 
                                                    2138005SRWT4998BCE35 
      ---------------------------  ------------------------------------------------------- 
 4     Details of the transaction(s): section to be repeated for 
        (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transactions have 
        been conducted 
      ------------------------------------------------------------------------------------ 
 a.    Description of                Ordinary shares of GBP0.01 each 
        the financial                 GB00BMVMRB86 
        instrument, type 
        of instrument 
 
        Identification 
        Code 
      ---------------------------  ------------------------------------------------------- 
 b.    Nature of the                Acquisition of ordinary shares of GBP0.01 
        transaction                  each 
      ---------------------------  ------------------------------------------------------- 
 
 c.    Price(s) and volume(s)             Price(s)      Volume(s) 
      ---------------------------        ------------ 
    2.69 pence                                          340,010 
   --------------------------------------------------  ----------- 
 
 d.    Aggregated information       N/A - Single Transaction 
 
        - Aggregated Volume 
 
        - Price 
      ---------------------------  ------------------------------------------------------- 
 e.    Date of the transaction      1(st) December 2021 
      ---------------------------  ------------------------------------------------------- 
 f.    Place of the transaction     London, UK 
      ---------------------------  ------------------------------------------------------- 
 
 

, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHQLLBBFLLLFBB

(END) Dow Jones Newswires

December 02, 2021 02:00 ET (07:00 GMT)